Castle Biosciences, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
327.49 |
293.94 |
298.64 |
324.87 |
355.95 |
385.55 |
Przychód Δ r/r |
0.00% |
-10.25% |
1.60% |
8.78% |
9.57% |
8.32% |
Przychód (min) |
322.66 |
289.60 |
287.46 |
324.84 |
350.69 |
379.85 |
Przychód (max) |
332.71 |
298.62 |
310.18 |
324.91 |
361.62 |
391.69 |
EBITDA (średnia) |
-66.68 |
-59.85 |
-60.81 |
-66.15 |
-72.47 |
-78.50 |
EBIT (średnia) |
-81.41 |
-73.07 |
-74.24 |
-80.76 |
-88.49 |
-95.85 |
EBIT % |
-24.86% |
-24.86% |
-24.86% |
-24.86% |
-24.86% |
-24.86% |
Zysk netto (średni) |
11.34 |
-80.45 |
-56.99 |
-65.15 |
-54.12 |
-44.47 |
Zysk netto % |
3.46% |
-27.37% |
-19.08% |
-20.05% |
-15.20% |
-11.53% |
EPS (średnia) |
0.39 |
-2.75 |
-1.98 |
-2.02 |
-1.85 |
-1.52 |
Liczba analityków (Przychody) |
3 |
5 |
9 |
4 |
2 |
3 |
Liczba analityków (EPS) |
6 |
4 |
8 |
3 |
1 |
1 |
symbol |
CSTL |
CSTL |
CSTL |
CSTL |
CSTL |
CSTL |